跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 123 条关于
“PDGFRA-D842V”
全部
123
临床试验
50
药物
18
机构
0
资讯
55
4个月前
Ayvakit (Avapritinib): High Response Rates in Rare Cancers and Mastocytosis, With Critical Safety Monitoring Requirements
去年
Precision Medicine Framework Improves Treatment Strategies for GIST and Sarcoma
11个月前
Swissmedic Approves Two Orphan Drugs for Rare Cancers: Ayvakyt for GIST and Mastocytosis, VANFLYTA for FLT3-ITD AML
2年前
Real-World Study Highlights Adverse Events Associated with Lenvatinib Use
19天前
Multi-Omics Maps Compartment-Specific Gut-Kidney Axis in Diabetic Kidney Disease, Prioritizing Caffeic Acid and Naringenin Chalcone
去年
Onco360 Partners with Deciphera to Distribute QINLOCK for Advanced GIST Patients
去年
Zai Lab's Augtyro Included in China's National Reimbursement Drug List for ROS1+ NSCLC
8个月前
CATNON Trial Final Results Confirm Adjuvant Temozolomide Benefit in IDH-Mutant Anaplastic Glioma
11个月前
Eisai Presents 5-Year Survival Data for Lenvatinib Plus Pembrolizumab in Endometrial Cancer at ESMO 2025
去年
Ripretinib Demonstrates Efficacy as Neoadjuvant Therapy for GIST in First Case Report
第 1 页,共 6 页
上一页
下一页